Rationale and design of the Hellenic Registry of Clinical events and Adherence to Lipid LowerINg therapy In aCUte coronary Syndrome (CALLINICUS-Hellas Registry)-Reference-Cited by-同舟云学术

Rationale and design of the Hellenic Registry of Clinical events and Adherence to Lipid LowerINg therapy In aCUte coronary Syndrome (CALLINICUS-Hellas Registry)

Published:2022-07 Issue: Volume:66 Page:84-86
ISSN:1109-9666
Container-title:Hellenic Journal of Cardiology
language:en
Short-container-title:Hellenic Journal of Cardiology

Author:

Rallidis Loukianos S.,Tasoulas Dimitrios,Leventis Ioannis,Malkots Belkis,Kladou Eleni,Zapantiotis Dimitrios,Theofilatos Athinagoras,Zormpas Georgios,Kalogeras Petros,Betsis Christos,Lykoudis Anastasios,Tsamoulis Donatos,Kalantzis Charalampos,Miliotou Argyro,Daios Stylianos,Delakis Iosif,Manolis George,Papathanasiou Konstantinos A.,Vlachopoulos Charalambos

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference7 articles.

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

2. Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population;Li;Clin Cardiol,2019

3. Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP);Banach;Pharmacol Res,2021

4. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study;Ray;Eur J Prev Cardiol,2021

5. The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients;Rallidis;Atherosclerosis,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06

2. Newly detected diabetes mellitus patients with acute coronary syndrome have an adverse cardiometabolic profile similar to patients with prior diabetes and a more extensive ischemic myocardial insult;Diabetes Research and Clinical Practice;2024-05

3. Extremely high-risk patients with acute coronary syndrome: How “extreme” should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?;Kardiologia Polska;2023-10-31